v3.25.1
Share-Based Compensation (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Share-Based Compensation [Abstract]    
Schedule of Share-Based Compensation Expense The Company did not record share-based compensation expense during the three months ended March 31, 2024.
   Three Months Ended
March 31,
 
   2025 
General and administrative  $964,632 
Research and development   19,761 
Total share-based compensation  $984,393 

The Company recorded share-based compensation expense in the following expense categories of its accompanying consolidated statements of operations:

   Year Ended
December 31,
 
   2024   2023 
General and administrative  $1,303,546   $52,000 
Research and development   20,390    
—
 
Total share-based compensation  $1,323,936   $52,000 
Schedule of Option Activity

The following table summarizes stock option activity for the three months ended March 31, 2025:

 

   Options   Weighted Average
Exercise Price
   Weighted Average
Remaining Life
(Years)
 
Balance at December 31, 2024   2,537,602   $5.60    7.85 
Granted   —    —      
Exercised   (147,579)   0.28      
Forfeited   (11,850)   5.11      
Balance at March 31, 2025   2,378,173   $5.89    7.67 
Vested and expected to vest   2,378,173   $5.89    7.67 
Exercisable at the end of the period   1,026,508   $0.18    5.67 

The following table summarizes option activity for the year ended December 31, 2024:

 

   Options   Weighted
Average
Exercise Price
   Weighted
Average
Remaining Life
(Years)
 
Balance at January 1, 2024   1,335,078   $0.23    5.83 
Granted   1,371,415    10.23      
Exercised   (160,991)   0.48      
Forfeited   (7,900)   10.23      
Balance at December 31, 2024   2,537,602   $5.60    7.85 
Vested and expected to vest   2,537,602   $5.60    7.85 
Exercisable at the end of the period   1,174,087   $0.19    5.90 
Schedule of RSU Activity

The following table summarizes RSU with Service-Only Conditions activity for the three months ended March 31, 2025:

 

   Awards   Weighted Average Grant Date Fair Value 
Balance at December 31, 2024   520,300   $8.13 
Granted   465,044    8.18 
Exercised   
—
    
—
 
Forfeited   (4,500)   5.11 
Balance at March 31, 2025   980,844   $8.17 

The following table summarizes RSU with Market-Based Conditions activity for the three months ended March 31, 2025:

 

   Awards   Weighted Average Grant Date Fair Value 
Balance at December 31, 2024   
—
   $
—
 
Granted   496,483    10.09 
Exercised   
—
    
—
 
Forfeited   
—
    
—
 
Balance at March 31, 2025   496,483   $10.09 

The following table summarizes RSU activity for the year ended December 31, 2024:

 

   Awards   Weighted
Average
Grant Date
Fair Value
 
Balance at January 1, 2024   
—
   $
—
 
Granted   523,300    8.15 
Vested   
—
    
—
 
Forfeited   (3,000)   10.23 
Balance at December 31, 2024   520,300   $8.13 
Schedule of Assumptions Used to Estimate the Fair Value of the RSUs With Market-based Conditions The following summarizes the assumptions used to estimate the fair value of the RSUS with market-based conditions that were granted during the three months ended March 31, 2025:
RSUs - Market-Based Conditions    
Expected term - years   2.9 
Expected volatility   89.7%
Risk-free interest rate   4.3%
Expected dividends   — 
 
Schedule of Options Granted  

The following tables provide additional detail about the options granted during the year ended December 31, 2024:

Grant Date  NSO
Options(1)
(#)
   Exercise
Price
($)
 
June 6, 2024   651,737  (3)    10.23 
September 9, 2024(2)   177,747    10.23 
(1)One-fourth of the total number of shares of Class A common stock subject to the NSOs vest and become exercisable on June 6, 2025, and one-sixteenth of the total number of shares of Class A common stock subject to the Option shall vest and become exercisable on each three (3)-month anniversary thereafter, subject to the applicable employee’s continued service through the applicable vesting date
  
(2)The vesting commencement date for NSOs granted on September 9, 2024 is June 6, 2024. Per ASC 718-10-35-2, compensation cost for an award of share-based compensation is recognized over the requisite service period. The service period for these awards begins on grant date. The Company considered the requirement in ASC 718-10-35-8 when recognizing current period expense.
  
(3)7,900 options were forfeited during the year ended December 31, 2024 which resulted in a reversal of share-based compensation expense of $2,667 as the Company accounts for forfeitures as they occur.

 

Non-employee Directors
Grant Date  NSO
Options(1)
(#)
   Exercise
Price
($)
 
June 6, 2024   99,540    10.23 
(1)These NSOs vest and become exercisable in full on the earlier of (i) the one year anniversary of the grant date and (ii) the date of the next annual shareholders’ meeting of the Company following the grant date, subject to the applicable non-employee director’s continued service through the applicable vesting date.

 

Non-employee Equity Method Investees
Grant Date  NSO
Options(1)
(#)
   Exercise
Price
($)
 
June 6, 2024   65,832    10.23 
September 9, 2024(2)   376,560    10.23 
(1)One-fourth of the total number of shares of Class A common stock subject to the NSOs vest and become exercisable on June 6, 2025, and one-sixteenth of the total number of shares of Class A common stock subject to the Option shall vest and become exercisable on each three (3)-month anniversary thereafter, subject to the applicable recipient’s continued service through the applicable vesting date
  
(2)The vesting commencement date for NSOs granted on September 9, 2024 is June 6, 2024. Per ASC 718-10-35-2, compensation cost for an award of share-based compensation is recognized over the requisite service period. The service period for these awards begins on grant date. The Company considered the requirement in ASC 718-10-35-8 when recognizing current period expense.
Schedule of Fair Value of NSOs Determined Using Black-Scholes Option-Pricing Model  

The fair value of the NSOs were determined using the Black-Scholes option-pricing model and were based on the following weighted average assumptions:

 

   Grant Date 
  June 6,
2024
   September 9,
2024
 
Incentive Plan          
Expected term – years   6.1    10.0 
Expected volatility   29.5%   28.5%
Risk-free interest rate   4.2%   3.7%
Expected dividends   
—
    
—
 
Schedule of RSUs Granted  

The following tables provide additional detail about the RSUs granted during the year ended December 31, 2024:

 

Employees
Grant Date  Awards(1)
(#)
   Grant Date
Fair Value
($)
 
June 6, 2024   247,500(3)   10.23 
September 9, 2024(2)   70,000    5.11 
(1)These awards vest as to 25% of the total awards granted on each of the first four anniversaries of the applicable vesting commencement date, subject to the applicable employee’s continued service through the applicable vesting date.
  
(2)The vesting commencement date for RSUs granted on September 9, 2024 is June 6, 2024. Per ASC 718-10-35-2, compensation cost for an award of share-based compensation is recognized over the requisite service period. The service period for these awards begins on grant date. The Company considered the requirement in ASC 718-10-35-8 when recognizing current period expense.
  
(3)3,000 awards were forfeited during the year ended December 31, 2024 which resulted in a reversal of share-based compensation expense of $2,666 as the Company accounts for forfeitures as they occur.

 

Non-employee Directors
Grant Date  Awards(1)
(#)
   Grant Date
Fair Value
($)
 
June 6, 2024   37,800    10.23 
(1)These awards vest in full on the earlier of (i) the one (1) year anniversary of the grant date and (ii) the date of the next annual shareholders’ meeting of the Company following the grant date, subject to the applicable non-employee director’s continued service through the applicable vesting date.

 

Non-employee Equity Method Investees
Grant Date  Awards(1)
(#)
   Grant Date
Fair Value
($)
 
June 6, 2024   25,000    10.23 
September 9, 2024(2)   143,000    5.11 
(1)These awards vest as to 25% of the total awards granted on each of the first four anniversaries of the applicable vesting commencement date, subject to the applicable recipient’s continued service through the applicable vesting date.

 

(2)The vesting commencement date for RSUs granted on September 9, 2024 is June 6, 2024. Per ASC 718-10-35-2, compensation cost for an award of share-based compensation is recognized over the requisite service period. The service period for these awards begins on grant date. The Company considered the requirement in ASC 718-10-35-8 when recognizing current period expense.